psoriasis

Fortnightly secukinumab better for heavier psoriasis patients

Risankizumab can be used in patients with Crohn’s

Impact of dermatological disease is more than skin deep

MS linked to psoriasis risk in family members

Psoriasis drug passes another milestone

TGA approval for psoriasis

Promising findings for PsA treatments
